Clinical Trial Update: The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating nicotinamide riboside versus placebo for Huntington's disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: Oslo University Hospital | Conditions: Huntington Disease | Phase 2 | Status: RECRUITING